Andzonbio1 Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.27M

  • Investors
  • 2

Andzonbio1 General Information

Description

Operator of a biotech company intended to focus on developing treatments for cardiovascular, renal, and metabolic diseases. The company helps to identify and develop a breakthrough therapeutic program to address the unmet medical needs, enabling healthcare professionals to accelerate the development of the academic projects with more effective treatments and preventive strategies.

Contact Information

Website
www.andzonbio1.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10 rue d'Oradour-sur-Glane
  • 75015 Paris
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 10 rue d'Oradour-sur-Glane
  • 75015 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Andzonbio1 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 31-Oct-2024 $3.27M Completed Startup
To view Andzonbio1’s complete valuation and funding history, request access »

Andzonbio1 Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
ABSA 2024
To view Andzonbio1’s complete cap table history, request access »

Andzonbio1 Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
AdBio partners Venture Capital Minority
Inserm Transfert VC-Backed Company Minority
To view Andzonbio1’s complete investors history, request access »

Ready to get started?

Request a free trial

Andzonbio1 FAQs

  • When was Andzonbio1 founded?

    Andzonbio1 was founded in 2024.

  • Where is Andzonbio1 headquartered?

    Andzonbio1 is headquartered in Paris, France.

  • What industry is Andzonbio1 in?

    Andzonbio1’s primary industry is Drug Discovery.

  • Is Andzonbio1 a private or public company?

    Andzonbio1 is a Private company.

  • What is the current valuation of Andzonbio1?

    The current valuation of Andzonbio1 is .

  • What is Andzonbio1’s current revenue?

    The current revenue for Andzonbio1 is .

  • How much funding has Andzonbio1 raised over time?

    Andzonbio1 has raised $3.27M.

  • Who are Andzonbio1’s investors?

    AdBio partners and Inserm Transfert have invested in Andzonbio1.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process